{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:40:18Z","timestamp":1759956018200,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal des Maladies Vasculaires"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.jmv.2008.07.092","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T04:40:17Z","timestamp":1222404017000},"page":"229-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Syndrome de compression des loges bilat\u00e9ral des membres inf\u00e9rieurs et myon\u00e9crose s\u00e9v\u00e8re due \u00e0 l\u2019usage inappropri\u00e9 de la simvastatine"],"prefix":"10.1016","volume":"33","author":[{"given":"M.","family":"Chochola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Lubanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Skalicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Varejka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Horejs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Prskavec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bal\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Semr\u00e1d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmv.2008.07.092_bib1","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1345\/aph.10228","article-title":"Rhabdomyolysis and HMG-CoA reductase inhibitors","volume":"35","author":"Omar","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmv.2008.07.092_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions","volume":"363","author":"Collins","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmv.2008.07.092_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jmv.2008.07.092_bib4","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jmv.2008.07.092_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmv.2008.07.092_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmv.2008.07.092_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jmv.2008.07.092_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0009-9236(98)90165-5","article-title":"Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole","volume":"63","author":"Neuvonen","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmv.2008.07.092_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/106002809703100710","article-title":"Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin","volume":"31","author":"Grunden","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmv.2008.07.092_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9236(98)90034-0","article-title":"Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid","volume":"63","author":"Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmv.2008.07.092_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0009-9236(98)90067-4","article-title":"The interaction of diltiazem with lovastatin and pravastatin","volume":"64","author":"Azie","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmv.2008.07.092_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1472-8206.1999.tb00344.x","article-title":"Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokinetics","volume":"13","author":"Becquemont","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jmv.2008.07.092_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/mcp.2001.115542","article-title":"Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate","volume":"69","author":"Kyrklund","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmv.2008.07.092_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmv.2008.07.092_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mcp.2000.108507","article-title":"Plasma concentrations of active simvastatin acid are increased by gemfibrozil","volume":"68","author":"Backman","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmv.2008.07.092_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000187874","article-title":"Rhabdomyolysis and acute renal failure associated with lovastatin","volume":"66","author":"Fernandez","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.jmv.2008.07.092_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1345\/aph.19039","article-title":"Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine","volume":"33","author":"Maltz","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmv.2008.07.092_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/106002809502907-818","article-title":"Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia","volume":"29","author":"Hsu","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmv.2008.07.092_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jmv.2008.07.092_bib20","first-page":"A3","article-title":"Bayer recall spurs Europe to wide review","author":"Fuhrmans","year":"2001","journal-title":"Wall Street Journal"},{"key":"10.1016\/j.jmv.2008.07.092_bib21","first-page":"205","article-title":"Withdrawal of cerivastatin from the world market","volume":"2","author":"Furberg","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.jmv.2008.07.092_bib22","first-page":"15","article-title":"Rhabdomyolysis: a comprehensive guide","volume":"21","author":"Dayer-Berenson","year":"1994","journal-title":"ANNA J"},{"key":"10.1016\/j.jmv.2008.07.092_bib23","first-page":"153","article-title":"Rhabdomyolysis","volume":"12","author":"Kiely","year":"1986","journal-title":"J Emerg Nurs"},{"key":"10.1016\/j.jmv.2008.07.092_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/pgmj.2006.051334","article-title":"Simvastatin-induced bilateral leg compartment syndrome and myonecrosis associated with hypothyroidism","volume":"83","author":"Ramdas","year":"2007","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jmv.2008.07.092_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/026988110401800316","article-title":"Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin","volume":"18","author":"Webber","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jmv.2008.07.092_bib26","first-page":"325","article-title":"Rhabdomyolysis as a side effect of simvastatin treatment","volume":"59","author":"Iskra","year":"2005","journal-title":"Acta Med Croatica"},{"key":"10.1016\/j.jmv.2008.07.092_bib27","first-page":"423","article-title":"Hypothyroidism presenting as hypercholesterolemia and simvastatin-induced myositis","volume":"6","author":"Hung","year":"2000","journal-title":"Hong Kong Med J"}],"container-title":["Journal des Maladies Vasculaires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398049908002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398049908002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:10:42Z","timestamp":1759954242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398049908002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":27,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0398049908002928"],"URL":"https:\/\/doi.org\/10.1016\/j.jmv.2008.07.092","relation":{},"ISSN":["0398-0499"],"issn-type":[{"type":"print","value":"0398-0499"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome de compression des loges bilat\u00e9ral des membres inf\u00e9rieurs et myon\u00e9crose s\u00e9v\u00e8re due \u00e0 l\u2019usage inappropri\u00e9 de la simvastatine","name":"articletitle","label":"Article Title"},{"value":"Journal des Maladies Vasculaires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmv.2008.07.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}